Ensysce Biosciences's total assets for Q3 2024 were $9.38M, an increase of 235.69% from the previous quarter. ENSC total liabilities were $2.80M for the fiscal quarter, a 113.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.